234 related articles for article (PubMed ID: 29172719)
1. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
2. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
[TBL] [Abstract][Full Text] [Related]
3. Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.
Ye J; Liu Q; Fu Q; Li B; Huang J; Zeng G
J Coll Physicians Surg Pak; 2023 Apr; 33(4):421-426. PubMed ID: 37190715
[TBL] [Abstract][Full Text] [Related]
4. Potential role of autophagy in T‑cell survival in polymyositis and dermatomyositis.
Shu X; Chen F; Peng Q; Lu X; Tian X; Wang Y; Wang G
Mol Med Rep; 2017 Aug; 16(2):1180-1188. PubMed ID: 28586060
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
Chino Y; Murata H; Goto D; Matsumoto I; Tsutsumi A; Sakamoto T; Ohtsuka M; Sekisawa K; Ito S; Sumida T
Int J Mol Med; 2006 Jan; 17(1):101-9. PubMed ID: 16328018
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.
Wang DX; Lu X; Zu N; Lin B; Wang LY; Shu XM; Ma L; Wang GC
Clin Rheumatol; 2012 Dec; 31(12):1691-7. PubMed ID: 22933126
[TBL] [Abstract][Full Text] [Related]
7. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
8. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis.
Iannone F; Cauli A; Yanni G; Kingsley GH; Isenberg DA; Corrigall V; Panayi GS
Br J Rheumatol; 1996 Sep; 35(9):839-45. PubMed ID: 8810666
[TBL] [Abstract][Full Text] [Related]
10. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
[TBL] [Abstract][Full Text] [Related]
11. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of lymphocyte subpopulations and TH1/TH2 balance in patients with polymyositis and dermatomyositis.
Ishii W; Matsuda M; Shimojima Y; Itoh S; Sumida T; Ikeda S
Intern Med; 2008; 47(18):1593-9. PubMed ID: 18797118
[TBL] [Abstract][Full Text] [Related]
13. Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis.
Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmström V
Arthritis Res Ther; 2016 Apr; 18():80. PubMed ID: 27039301
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
Liu T; Hou Y; Dai TJ; Yan CZ
Chin Med J (Engl); 2017 Sep; 130(17):2101-2106. PubMed ID: 28836555
[TBL] [Abstract][Full Text] [Related]
15. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
Englund P; Wahlström J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
Arthritis Rheum; 2007 Jan; 56(1):372-83. PubMed ID: 17195241
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.
Goebels N; Michaelis D; Engelhardt M; Huber S; Bender A; Pongratz D; Johnson MA; Wekerle H; Tschopp J; Jenne D; Hohlfeld R
J Clin Invest; 1996 Jun; 97(12):2905-10. PubMed ID: 8675705
[TBL] [Abstract][Full Text] [Related]
17. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells.
Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Horiuchi T; Miyake K; Nagasawa K
Ann Rheum Dis; 2001 Dec; 60(12):1137-40. PubMed ID: 11709456
[TBL] [Abstract][Full Text] [Related]
18. [MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis].
Graça CR; Kouyoumdjian JA
Rev Bras Reumatol; 2015; 55(3):203-8. PubMed ID: 25600456
[TBL] [Abstract][Full Text] [Related]
19. Altered chemokine receptor expression in the peripheral blood lymphocytes in polymyositis and dermatomyositis.
Zhu Z; Yang C; Wang J; Feng Q; Chen Q; Yang P
Cytokine; 2017 Nov; 99():316-321. PubMed ID: 28869080
[TBL] [Abstract][Full Text] [Related]
20. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
Kim GT; Cho ML; Park YE; Yoo WH; Kim JH; Oh HJ; Kim DS; Baek SH; Lee SH; Lee JH; Kim HY; Kim SI
Clin Rheumatol; 2010 Mar; 29(3):273-9. PubMed ID: 19953283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
